Unassociated Document

 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 
F O R M 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of November 2016
 
ELTEK LTD.
(Name of Registrant)
 
Sgoola Industrial Zone, Petach Tikva, Israel
(Address of Principal Executive Office)
 
    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F x Form 40-F o
 
    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
 
    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
 
    Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 
Yes o No x
 
    If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ____________
 
This Form 6-K is being incorporated by reference into the Registrant’s Form S-8 Registration Statements File Nos. 333-12012 and 333-123559.
 

 
SIGNATURES
 
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
  ELTEK LTD.
(Registrant)
 
       
By:
/s/ Amnon Shemer  
    Amnon Shemer  
   
Chief Financial Officer
 
       
Date: November 16, 2016
 

Press Release
 
Eltek Reports 2016 Third Quarter Financial Results

·
Revenues of $9.3 million in the third quarter of 2016
·
Gross profit of $880,000
·
Net loss of $446,000
·
Positive net cash flow of $643,000 from operating activities

PETACH-TIKVA, Israel, November 16, 2016 - Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, announced today its financial results for the quarter ended September 30, 2016.

Mr. Yitzhak Nissan, Chairman of the Board and Chief Executive Officer, commented: “Third quarter revenues ($9.3 million) were lower than the revenues in the third quarter of 2015 ($10.8 million). The decrease was due to competitive pressures in Israel and certain European countries, and a continued weakness in the German PCB market, which led to a decline in sales of our subsidiary, Kubatronik. We have also experienced operational difficulties that impeded our ability to meet the demand for our products. We have recently made several changes in our manufacturing operations to address these difficulties.

The demand for our products in Italy and the Netherlands was strong. We believe that the growing need for complex PCBs in the defense industry will benefit us in the long run. We remain focused on our target to become the leading company in our field in terms of technology, on-time delivery and product quality," Mr. Nissan concluded.

Highlights of the Third Quarter of 2016

·
Revenues for the third quarter of 2016 were $9.3 million, compared to $10.8 million in the third quarter of 2015.
 

·
Gross profit was $880,000 (10% of revenues), compared to a gross profit of $1.7 million (16% of revenues) in the third quarter of 2015. The decrease in gross profit and gross margins reflects the decrease in revenues and the pricing challenges we have faced in this quarter.
 
·
Operating loss was $338,000, compared to an operating profit of $607,000 in the third quarter of 2015;
 
·
Net loss was $446,000 or $0.04 per fully diluted share, compared to a net profit of $624,000 or $0.06 per fully diluted share in the third quarter of 2015;
 
·
EBITDA amounted to $164,000 compared to EBITDA of $1.0 million  in the third quarter of 2015;
 
·
Net cash provided by operating activities amounted to $643,000, compared to net cash provided by operating activities of $639,000 in the third quarter of 2015;
 
·
Shareholders' equity as of September 30, 2016 amounted to $10 million, compared to $10.2 million as of December 31, 2015;
 
·
Cash and cash equivalents as of September 30, 2016 were $842,000, compared to $1.0 million as of December 31, 2015.
 
Highlights for the first nine months of 2016

·
Revenues for the first nine months of 2016 were $29 million, compared to $30.9 million in the first nine months of 2015.
 
·
Gross profit was $3.3 million (11% of revenues), compared to a gross profit of $4.9 million (16% of revenues) in the first nine months of 2015.
 
·
Operating loss was $387,000, compared to an operating profit of $1 million in the first nine months of 2015;
 

·
Net loss was $617,000, or $0.06 per fully diluted share, compared to a net profit of $814,000 or $0.08 per fully diluted share in the first nine months of 2015;
 
·
EBITDA amounted to $1.1 million, compared to EBITDA of $2.4 million in the first nine months of 2015;
 
·
Net cash provided by operating activities amounted to $1.5 million, compared to net cash provided by operating activities of $349,000 in the first nine months of 2015.
 
Conference Call
Today, Wednesday, November 16, 2016 at 9:30 a.m. Eastern Time, Eltek will conduct a conference call to discuss the results. The call will feature remarks by Mr. Yitzhak Nissan, Chairman of the Board of Directors and Chief Executive Officer, Mr. Roberto Tulman, Deputy CEO and Chief Technology Officer, and Mr. Amnon Shemer, Chief Financial Officer.
 
To participate, please call the following teleconference numbers. Please allow for additional time to connect prior to the call:
 
United States:
1-888-281-1167
Israel:
03-9180644
International:
+972-3-9180644

At:

9:30 a.m. Eastern Time
6:30 a.m. Pacific Time
16:30 p.m. Israel Time

A replay of the call will be available through the Investor Info section on Eltek’s corporate website at www.nisteceltek.com approximately 24 hours after the conference call is completed and will be archived for 30 days.

(Tables follow)


About Eltek
Eltek – "Innovation Across the Board", is a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs), and is the Israeli leader in this industry. PCBs are the core circuitry of most electronic devices. Eltek specializes in the manufacture and supply of complex and high quality PCBs, HDI, multilayered and flex-rigid boards for the high-end market. Eltek has ITAR, AS-9100 and NADCAP Electronics permits and its customers include top of the line companies in the defense, aerospace and medical industries in Israel, the United States, Europe and Asia.

Eltek was founded in 1970. The Company’s headquarters, and R&D, production and marketing center is located in Israel. Eltek operates also through its subsidiaries in North America in Europe and by agents and distributors in Europe, India, South Africa and South America.

For more information, visit Eltek's web site at www.nisteceltek.com.
 
Use of Non-GAAP Financial Information
 
The Company reports financial results in accordance with U.S. GAAP and herein provides some non-GAAP measures, including EBITDA. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. These non-GAAP measures are intended to supplement the Company’s presentation of its financial results that are prepared in accordance with GAAP. The Company uses the non-GAAP measures presented to evaluate and manage the Company’s operations internally. The Company is also providing this information to assist investors in performing additional financial analysis. Reconciliation between the company's results on a GAAP and non-GAAP basis is provided in a table below.
 
Forward Looking Statements:
Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to statements regarding expected results in future quarters, risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors detailed in the Company's Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission.

Investor Contact:
Nir Zalik
KM Investor relations
Tel: +972- 3-5167620
nir@km-ir.co.il
www.km-ir.co.il

Amnon Shemer
Chief Financial Officer
amnons@nisteceltek.com
+972-3-9395023


Eltek Ltd.
Consolidated Statements of Operations
(In thousands US$, except per share data)
 
   
Three months ended
   
Nine months ended
 
   
September 30,
   
September 30,
 
   
2016
   
2015
   
2016
   
2015
 
             
Revenues
   
9,252
     
10,843
     
28,956
     
30,943
 
Costs of revenues
   
(8,372
)
   
(9,114
)
   
(25,677
)
   
(26,086
)
                                 
Gross profit
   
880
     
1,729
     
3,279
     
4,857
 
                                 
Selling, general and administrative expenses
   
(1,185
)
   
(1,173
)
   
(3,569
)
   
(3,758
)
                                 
R&D expenses, net
   
(34
)
   
51
     
(97
)
   
(57
)
                                 
Operating profit (loss)
   
(338
)
   
607
     
(387
)
   
1,042
 
                                 
Financial expenses, net
   
(114
)
   
62
     
(211
)
   
(143
)
                                 
Profit (loss) before other income, net
   
(452
)
   
669
     
(599
)
   
899
 
                                 
Other income, net
   
0
     
0
     
0
     
5
 
                                 
Profit (loss) before income tax expenses
   
(452
)
   
669
     
(598
)
   
904
 
                                 
Tax expenses
   
(29
)
   
(45
)
   
(77
)
   
(76
)
                                 
Net Profit (loss)
   
(481
)
   
624
     
(675
)
   
828
 
                                 
Net loss attributable to non controlling interest
   
(34
)
   
0
     
(58
)
   
14
 
                                 
Net Profit (loss) attributable to Eltek Ltd.
   
(446
)
   
624
     
(617
)
   
814
 
                                 
Earnings per share
                               
                                 
Basic and diluted net gain (loss) per ordinary share
   
(0.04
)
   
0.06
     
(0.06
)
   
0.08
 
                                 
Weighted average number of ordinary shares
                               
used to compute basic and diluted net gain (loss) per
                               
ordinary share (in thousands)
   
10,143
     
10,143
     
10,143
     
10,143
 
 


Eltek Ltd.
Consolidated Balance Sheets
(In thousands US$)
 
   
September 30,
   
December 31,
 
   
2016
   
2015
 
Assets
           
             
Current assets
           
Cash and cash equivalents
   
842
     
1,038
 
Receivables:   Trade, net of provision for doubtful accounts
   
6,786
     
8,015
 
                          Other
   
272
     
273
 
Inventories
   
4,834
     
4,450
 
Prepaid expenses
   
321
     
187
 
                 
Total current assets
   
13,055
     
13,963
 
                 
Deferred taxes
   
1,082
     
1,064
 
                 
Assets held for employees' severance benefits
   
51
     
49
 
                 
Fixed assets, less accumulated depreciation
   
9,611
     
10,067
 
                 
Intangible asset
   
330
     
276
 
                 
Total assets
   
24,129
     
25,419
 
                 
Liabilities and Shareholder's equity
               
                 
Current liabilities
               
Short-term credit and current maturities of long-term debts
   
1,244
     
1,275
 
Accounts payable: Trade
   
5,910
     
6,112
 
                                  Other
   
4,511
     
4,594
 
                 
Total current liabilities
   
11,665
     
11,981
 
                 
Long-term liabilities
               
Long term debt, excluding current maturities
   
2,205
     
2,905
 
Employee severance benefits
   
299
     
289
 
                 
Total long-term liabilities
   
2,504
     
3,194
 
                 
Equity
               
Ordinary shares, NIS 0.6  par value authorized 50,000,000 shares, issued and outstanding 10,142,762
   
1,985
     
1,985
 
Additional paid-in capital
   
17,270
     
17,270
 
Cumulative foreign currency translation adjustments
   
2,287
     
1,892
 
Capital reserve
   
695
     
695
 
Accumulated deficit
   
(12,125
)
   
(11,507
)
Shareholders' equity
   
10,112
     
10,335
 
Non controlling interest
   
(152
)
   
(91
)
Total equity
   
9,960
     
10,244
 
Total liabilities and shareholders' equity
   
24,129
     
25,419
 
 


Eltek Ltd.
Unaudited Non-GAAP EBITDA Reconciliations
(In thousands US$)
 
Non-GAAP EBITDA Reconciliations
 
Three months ended
   
Nine months ended
 
   
September 30,
   
September 30,
 
   
2016
   
2015
   
2016
   
2015
 
                         
GAAP net Income (loss)
   
(446
)
   
624
     
(617
)
   
814
 
Add back items:
                               
                                 
Financial expenses (income), net
   
114
     
(62
)
   
211
     
143
 
Income tax expense
   
29
     
45
     
77
     
76
 
Depreciation and amortization
   
467
     
435
     
1,413
     
1,361
 
Adjusted EBITDA
   
164
     
1,041
     
1,084
     
2,394
 
 


Eltek Ltd.
Consolidated Statement of  Cash flow
(In thousands US$, except per share data)
 
   
Three months ended
   
Nine months ended
 
   
September 30,
   
September 30,
 
   
2016
   
2015
   
2016
   
2015
 
                         
Cash flows from operating activities:
                       
                         
Net Income (loss)
   
(481
)
   
624
     
(675
)
   
827
 
                                 
Adjustments to reconcile net loss to net
                               
 cash flows provided by operating activities:
                               
Depreciation and amortization
   
467
     
435
     
1,413
     
1,285
 
Capital lose on disposal of fixed assets, net
           
-
     
-
     
76
 
Revaluation of long term loans
   
-
     
25
     
1
     
28
 
Decrease (increase) in Deferred Tax
   
8
     
-
     
22
     
-
 
     
475
     
460
     
1,436
     
1,389
 
                                 
Decrease (increase) in trade receivables
   
928
     
(305
)
   
1,502
     
(21
)
Decrease (increase) in other receivables and prepaid expenses
   
(132
)
   
(107
)
   
(114
)
   
(5
)
Decrease (increase) in inventories
   
(108
)
   
376
     
(214
)
   
(67
)
Increase (decrease) in trade payables
   
171
     
(286
)
   
(183
)
   
(1,036
)
Increase (decrease) in other liabilities and accrued expenses
   
(206
)
   
(113
)
   
(255
)
   
(680
)
Increase (decrease) in employee severance benefits, net
   
(5
)
   
(10
)
   
(2
)
   
(59
)
     
649
     
(445
)
   
734
     
(1,867
)
                                 
Net cash provided by operating activities
   
643
     
639
     
1,495
     
349
 
                                 
Cash flows from investing activities:
                               
Owners investment
                               
Purchase of fixed assets
   
(231
)
   
(111
)
   
(561
)
   
(603
)
Purchase of Intangible asset
   
(22
)
   
-
     
(43
)
   
-
 
Net cash used in investing activities
   
(253
)
   
(111
)
   
(604
)
   
(603
)
                                 
Cash flows from financing activities:
                               
Increase (decrease) in short- term credit
   
(158
)
   
(65
)
   
(67
)
   
(979
)
Repayment of long-term loans from bank
   
(176
)
   
(78
)
   
(506
)
   
(96
)
Proceeds from long-term loans
   
-
     
-
     
-
     
1,707
 
Repayment of credit from fixed asset payables
   
(158
)
   
(74
)
   
(552
)
   
(370
)
Net cash provided by (used in) financing activities
   
(491
)
   
(217
)
   
(1,125
)
   
262
 
                                 
Effect of translation adjustments
   
50
     
(87
)
   
38
     
81
 
                                 
Net increase (decrease) in cash and cash equivalents
   
(52
)
   
224
     
(196
)
   
89
 
                                 
Cash and cash equivalents at beginning of the period
   
894
     
994
     
1,038
     
1,129
 
                     
 
         
Cash and cash equivalents at period end
   
842
     
1,218
     
842
     
1,218